General
Preferred name
BENDROFLUMETHIAZIDE
Synonyms
Naturetin ()
Aprinox ()
Bendrofluazide ()
NSC-758229 ()
Naturetin-2.5 ()
Berkozide ()
Neo-Bendromax 5 ()
Naturetin-5 ()
Benzydroflumethiazide ()
Naturetin-10 ()
Urizide ()
Neo-Bendromax 2.5 ()
Neo-Naclex ()
Centyl ()
Bendroflumethiazide ()
P&D ID
PD001076
CAS
73-48-3
Tags
natural product
drug
available
Approved by
FDA
First approval
1959
Drug Status
approved
Drug indication
Antihypertensive
Diuretic
High blood pressure
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Bendroflumethiazide is a thiazide diuretic. (GtoPdb)
Compound Sets
21
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
33
Properties
(calculated by RDKit )
Molecular Weight
421.04
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
2
cLogP
1.63
TPSA
118.36
Fraction CSP3
0.2
Chiral centers
1.0
Largest ring
6.0
QED
0.7
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Metabolism
Target
Carbonic Anhydrase
Potassium Channel
Therapeutic Class
Antihypertensive Agents
Source data